glp 1 anesthesia guidelines 2025 Updated guidance for patients using GLP-1/GIP receptor agonists GLP-1s are changing what we – New therapeutic agents for type

One GLP-1RA, liraglutide, has been approved to treat obesity, and another, semaglutide, is in clinical trials

For residents in Jackson, Gulfport, Southaven, Hattiesburg, and rural counties alike, securing a prescription for GLP-1 medications like semaglutide or tirzepatide has historically meant navigating months-long endocrinology waitlists, insurance prior authorisation battles, and the reality that brand-name Ozempic or Wegovy can run $1,200$1,500 per month out-of-pocket

GLP-1 receptor agonists improve liver enzymes primarily through indirect mechanisms including enhanced insulin sensitivity, reduced hepatic fat accumulation, weight loss, and decreased inflammatory cytokine production

Cardiovasc Res 118(17):32723287

Therefore, evidence-based counseling helps maintain trust while supporting appropriate treatment decisions